RxDoctor Payments Data

Ai Quoc Heller

Podiatrist · Las Vegas, NVNPI 1518213578

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,025 of the $8,141 with a category attached, or 86.3%. 22 manufacturers reported payments, led by Abbott at 31.6% of the total. Reporting peaked in 2021 at $2,859 and has fallen 89.2% since, to $310 in 2025.

$8,141in general payments, 2019–2025

Across 246 payments — averaging $33.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Stryker$2K
  • Goode Surgical Inc$843
  • Smith+Nephew$665
  • Amgen$371
  • Linvatec Corporation$233
  • plus $974 from 16 others

What the payments were for

  • Travel & lodging$1,11614%
  • Food & beverage$7,02586%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,141 in reported general payments places this provider in the 80th percentile of 44 podiatrist providers in Nevada.

See all podiatrist providers in Nevada

Medicare billing

Part B allowed, 2024
$102,238
Medicare patients
250
Services billed
2,384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox46$1,154
Cephalexin191$1,040
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen141$800
Pregabalin36$700
Methylprednisolone95$503
Gabapentin61$500
Ketoconazole25$471
Triamcinolone Acetonide32$447
Imiquimod12$305
Mupirocin21$229
Ibuprofen28$211
Clindamycin Hcl35$192
Meloxicam30$72
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$69
Allopurinol14$69

Paid to pharmacies, not to this prescriber.

Other podiatrist in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →